Medline Target Price

See Medline's analyst price targets ($45) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$32.11

Average Target Price

$44.56

38.8% upside

9 analysts in the last 4 months

High: $55 | Low: $37

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-27	BTIGDavid Larsen	$55	71.3% upside
2026-08-06	Robert W. BairdEric Coldwell	$42	30.8% upside
2026-08-06	Evercore ISI	$39	21.5% upside
2026-08-06	Stifel Nicolaus	$45	40.1% upside
2026-08-06	BMO CapitalSean Dodge	$47	46.4% upside
2026-08-06	RBC Capital	$46	43.3% upside
2026-08-06	Deutsche Bank	$37	15.2% upside
2026-06-03	Robert W. BairdEric Coldwell	$45	40.1% upside
2026-06-01	BarclaysGlen Santangelo	$45	40.1% upside
2026-05-07	Deutsche Bank	$42	30.8% upside
2026-03-09	Tigress FinancialIvan Feinseth	$60	86.9% upside
2026-02-25	Leerink PartnersMichael Cherny	$56	74.4% upside
2026-02-25	Stifel Nicolaus	$55	71.3% upside
2026-02-25	Evercore ISI	$55	71.3% upside
2026-02-05	Tigress Financial	$55	71.3% upside
2026-01-21	J.P. MorganDavid Larsen	$55	71.3% upside
2026-01-12	Barclays	$50	55.7% upside
2026-01-12	BNP Paribas	$38	18.3% upside
2026-01-12	Wolfe Research	$47	46.4% upside
2026-01-12	Deutsche Bank	$40	24.6% upside
2026-01-12	Wells Fargo	$42	30.8% upside
2026-01-12	BTIG	$50	55.7% upside
2026-01-12	Mizuho Securities	$48	49.5% upside
2026-01-12	UBS	$48	49.5% upside
2026-01-12	Stifel Nicolaus	$46	43.3% upside
2026-01-12	Redburn PartnersEd Ridley-Day	$42	30.8% upside
2026-01-12	Leerink Partners	$48	49.5% upside
2026-01-12	Evercore ISIElizabeth Anderson	$50	55.7% upside
2026-01-12	Bernstein	$49	52.6% upside
2026-01-12	Truist Financial	$52	61.9% upside
2026-01-12	Piper SandlerJason Bednar	$50	55.7% upside
2026-01-12	Robert W. BairdEric Coldwell	$48	49.5% upside
2026-01-12	BMO CapitalSean Dodge	$45	40.1% upside
2026-01-12	Goldman SachsDavid Roman	$49	52.6% upside
2026-01-12	RBC Capital	$47	46.4% upside
2026-01-11	Morgan StanleyPatrick Wood	$48	49.5% upside

Medline (MDLN) FAQ

Medline posts a target price of $45. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $45 for MDLN means covering analysts, on average, see the stock 38.8% upside of $32.11 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for MDLN's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Medline's other metric pages and overview cover the third.